Laurus Labs is back in focus as the latest research update resets the stock's price target, putting fresh attention on what ...

Laurus Labs Ltd. reported a 174% year-on-year increase in consolidated net profit to ₹252 crore for the third quarter of FY26, while revenue from operations grew 26% to ₹1,778 crore. The company's ...

Net Sales at Rs 1,509.42 crore in December 2025 up 19.3% from Rs. 1,265.19 crore in December 2024. Quarterly Net Profit at Rs ...

Laurus Labs' Q3 net profit soars to ₹252 crore with a 26% revenue increase, driven by strong generics and CDMO demand.

In its investor presentation, Laurus Labs said that they are well on track to deliver healthy operational growth for financial year 2026.

Laurus Labs Ltd (BOM:540222) reports robust financial results with significant growth in its generic division and strategic investments in advanced therapies.

Laurus Labs reported a significant 174% surge in net profit to ₹252 crore in Q3, driven by robust generic business and high demand in CDMO small molecule offerings.

Indian equity markets remain in a tight range in the weekly expiry session on Thursday. However, pockets of opportunity are emerging, with SEBI-registered analysts Kavita Agrawal and Vinay Taparia ...

Laurus Labs has seen a notable increase in its consensus analyst price target, which has risen from ₹724.14 to ₹815.86. This revision follows renewed analyst optimism, attributed largely to the ...

Laurus Labs posted a manifold increase in net profit to ₹252 crore in the third quarter ended December 31, 2025, compared to ₹92 crore in the corresponding quarter of the previous financial year on ...

SUNNYVALE, Calif., May 30, 2024 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of ...

The strategic alliance includes an initial seven high-value advanced intermediates and active pharmaceutical ingredients, including Willow's corticosteroid programs The agreement with Laurus is the ...